iifl-logo-icon 1

Emcure Pharmaceuticals Ltd Historical Data

937.55
(1.30%)
Mar 18, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Emcure Pharmaceuticals Ltd Historical Data

19/02/2025calendar-icon
19/03/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

17-Feb-2025

999

1,000945.396025,96116,73,12,143.0590,855

18-Feb-2025

971

1,018941.5985.5531,51936,07,22,671.499,736

19-Feb-2025

985

1,014.9970996.0515,12911,61,31,347.9580,501

20-Feb-2025

996.05

1,021.9985.899213,71913,92,59,359.21,02,974

21-Feb-2025

992

1,009.3980995.757,7338,92,02,297.853,903

24-Feb-2025

980

1,004.7973.5979.8510,72817,19,22,205.151,30,339

25-Feb-2025

979

1,012.1975987.76,9348,97,85,015.149,214

27-Feb-2025

988

993.2966.95976.611,8509,28,35,94261,200

28-Feb-2025

966.95

999.65960.05981.75,5599,14,18,396.6561,036

03-Mar-2025

979.4

979.4935.25956.59,3586,93,78,186.6542,279

04-Mar-2025

954.55

968.7936946.14,9166,47,30,220.8539,057

05-Mar-2025

946.1

977.75940.75965.55,3136,13,31,085.5541,687

06-Mar-2025

979.4

999971.39803,8074,49,84,256.518,626

07-Mar-2025

986.45

997.45969970.64,5404,36,20,366.9526,358

10-Mar-2025

970.6

977935940.27,74111,03,57,875.896,991

11-Mar-2025

944

962.1936945.58,7125,50,04,698.4523,930

12-Mar-2025

954

954922925.554,7973,74,95,482.427,465

13-Mar-2025

931

944.05916.75927.76,0787,66,54,812.351,344

17-Mar-2025

934

939.75910.95925.557,67715,01,03,945.61,18,297

Emcure Pharmaceuticals Ltd: Related NEWS

Emcure Pharma Posts 38% Profit Growth in Q2
11 Nov 2024|11:43 AM

EBITDA margin slightly declined, down 80 basis points to 20.8% in Q2, reflecting some operational pressures.

Read More
Emcure Pharma Soars 34.8% on NSE at Close
10 Jul 2024|03:39 PM

The allotment of shares was finalised on July 8, and Emcure Pharma shares were scheduled to be listed on the BSE and NSE on July 10.

Read More
Emcure Pharmaceuticals Lists at 31% Premium on the Bourses
10 Jul 2024|09:52 AM

The IPO comprised a mix of fresh equity sale and an offer for sale (OFS).

Read More
Emcure Pharma IPO Soars: Oversubscribed 66 Times on Day 3
5 Jul 2024|03:59 PM

The categories earmarked for NII and QIB investors received the most subscriptions, at 47.98 and 193.06 times, respectively.

Read More
Emcure Pharmaceuticals IPO subscribed 4.98 times on Day 2
5 Jul 2024|09:03 AM

The IPO is priced between Rs 960 and Rs 1008 a share, with buyers able to bid for 14 shares per lot.

Read More
Emcure Pharmaceuticals IPO Subscribed 1.32 times
4 Jul 2024|08:40 AM

According to BSE data, the initial share sale attracted bids for 1,80,40,960 shares, with 1,37,03,538 shares on offer.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.